Delineation of Interfaces on Human Alpha-Defensins Critical for Human Adenovirus and Human Papillomavirus Inhibition

PLoS Pathogens

Volumn 10, Issue 9, 2014, Pages

  Tenge, Victoria R ^a   Gounder, Anshu P ^a   Wiens, Mayim E ^a   Lu, Wuyuan ^b   Smith, Jason G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ARGININE; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; HUMAN ALPHA DEFENSIN 5; HUMAN NEUTROPHIL PEPTIDE 1; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PENTON; VIRUS PROTEIN; ALPHA-DEFENSIN 5, HUMAN; ANTIVIRUS AGENT;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL LINE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; GENETIC TRANSFECTION; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 5; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HYDROPHOBICITY; IC50; LD 50; MOLECULAR IMAGING; MOLECULAR INTERACTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOICHIOMETRY; SURFACE PLASMON RESONANCE; ULTRAVIOLET SPECTROSCOPY; VIRUS INFECTION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; WART VIRUS; ADENOVIRUS INFECTIONS, HUMAN; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN ADENOVIRUS C; MUTAGENESIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTEIN CONFORMATION; VIROLOGY; VIRUS ATTACHMENT;

HUMAN ADENOVIRUS; HUMAN PAPILLOMAVIRUS;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ALPHA-DEFENSINS; ANTIVIRAL AGENTS; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MUTAGENESIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTEIN CONFORMATION; SURFACE PLASMON RESONANCE; VIRUS ATTACHMENT;

EID: 84907588560     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004360     Document Type: Article

References (38)

1. Ganz T, (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710–720.
2. Lehrer RI, (2007) Multispecific myeloid defensins. Curr Opin Hematol 14: 16–21.
3. Selsted ME, Ouellette AJ, (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551–557.
4. Lehrer RI, Lu W, (2012) alpha-Defensins in human innate immunity. Immunol Rev 245: 84–112.
5. Wilson SS, Wiens ME, Smith JG, (2013) Antiviral mechanisms of human defensins. J Mol Biol 425: 4965–4980.
6. Shah R, Chang TL (2012) Defensins in Viral Infection. Small Wonders: Peptides for Disease Control: American Chemical Society. pp. 137–171.
7. Smith JG, Nemerow GR, (2008) Mechanism of adenovirus neutralization by human alpha-defensins. Cell Host Microbe 3: 11–19.
8. Nguyen EK, Nemerow GR, Smith JG, (2010) Direct evidence from single-cell analysis that human alpha-defensins block adenovirus uncoating to neutralize infection. J Virol 84: 4041–4049.
9. Smith JG, Silvestry M, Lindert S, Lu W, Nemerow GR, et al. (2010) Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog 6: e1000959.
10. Moyer CL, Wiethoff CM, Maier O, Smith JG, Nemerow GR, (2011) Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol 85: 2631–2641.
11. Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, et al. (2006) Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 103: 1516–1521.
12. Zins SR, Nelson CD, Maginnis MS, Banerjee R, O'Hara BA, et al. (2013) The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing ER traffic and stabilizing the viral capsid. J Virol 88: 948–960.
13. Rajabi M, Ericksen B, Wu X, de Leeuw E, Zhao L, et al. (2012) Functional determinants of human enteric alpha-defensin HD5: crucial role for hydrophobicity at dimer interface. J Biol Chem 287: 21615–21627.
14. Tai KP, Le VV, Selsted ME, Ouellette AJ, (2014) Hydrophobic Determinants of alpha-Defensin Bactericidal Activity. Infect Immun 82: 2195–2202.
15. Pazgier M, Wei G, Ericksen B, Jung G, Wu Z, et al. (2012) Sometimes it takes two to tango: contributions of dimerization to functions of human alpha-defensin HNP1 peptide. J Biol Chem 287: 8944–8953.
16. Gounder AP, Wiens ME, Wilson SS, Lu W, Smith JG, (2012) Critical determinants of human alpha-defensin 5 activity against non-enveloped viruses. J Biol Chem 287: 24554–24562.
17. Lynch JP, Fishbein M, Echavarria M, (2011) Adenovirus. Semin Respir Crit Care Med 32: 494–511.
18. Fox JP, Hall CE, Cooney MK, (1977) The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol 105: 362–386.
19. Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, et al. (1998) Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 152: 1247–1258.
20. Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, et al. (2005) Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem 280: 32921–32929.
21. Rajabi M, de Leeuw E, Pazgier M, Li J, Lubkowski J, et al. (2008) The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem 283: 21509–21518.
22. Flatt JW, Kim R, Smith JG, Nemerow GR, Stewart PL, (2013) An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS One 8: e61571.
23. Snijder J, Reddy VS, May ER, Roos WH, Nemerow GR, et al. (2013) Integrin and defensin modulate the mechanical properties of adenovirus. J Virol 87: 2756–2766.
24. Laver WG, Wrigley NG, Pereira HG, (1969) Removal of pentons from particles of adenovirus type 2. Virology 39: 599–604.
25. Lehrer RI, Jung G, Ruchala P, Andre S, Gabius HJ, et al. (2009) Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol 183: 480–490.
26. Wei G, Pazgier M, de Leeuw E, Rajabi M, Li J, et al. (2010) Trp-26 imparts functional versatility to human alpha-defensin HNP1. J Biol Chem 285: 16275–16285.
27. Cauet G, Strub JM, Leize E, Wagner E, Van Dorsselaer A, et al. (2005) Identification of the glycosylation site of the adenovirus type 5 fiber protein. Biochemistry 44: 5453–5460.
28. Chee-Sheung CC, Ginsberg HS, (1982) Characterization of a temperature-sensitive fiber mutant of type 5 adenovirus and effect of the mutation on virion assembly. J Virol 42: 932–950.
29. Caillet-Boudin ML, Strecker G, Michalski JC, (1989) O-linked GlcNAc in serotype-2 adenovirus fibre. Eur J Biochem 184: 205–211.
30. Pazgier M, Prahl A, Hoover DM, Lubkowski J, (2007) Studies of the biological properties of human beta-defensin 1. J Biol Chem 282: 1819–1829.
31. Varney KM, Bonvin AM, Pazgier M, Malin J, Yu W, et al. (2013) Turning Defense into Offense: Defensin Mimetics as Novel Antibiotics Targeting Lipid II. PLoS Pathog 9: e1003732.
32. Buck CB, Pastrana DV, Lowy DR, Schiller JT, (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751–757.
33. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT, (2005) Maturation of papillomavirus capsids. J Virol 79: 2839–2846.
34. Wu Z, Ericksen B, Tucker K, Lubkowski J, Lu W, (2004) Synthesis and characterization of human alpha-defensins 4–6. J Pept Res 64: 118–125.
35. Pace CN, Vajdos F, Fee L, Grimsley G, Gray T, (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4: 2411–2423.
36. Schneider CA, Rasband WS, Eliceiri KW, (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671–675.
37. Medina-Kauwe LK, Kasahara N, Kedes L, (2001) 3PO, a novel nonviral gene delivery system using engineered Ad5 penton proteins. Gene Ther 8: 795–803.
38. Zingler K, Young JA, (1996) Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses. J Virol 70: 7510–7516.